The Mass Spectrometry Shared Resource provides critical services to Cancer Center members whose research relies on structure determination of a variety of different molecules. Services currently provided by the Shared Resource include high and low resolution fast atom bombardment (FAB) ionization, high and low resolution electron ionization (El), and high and low resolution chemical ionization (CI). After the installation of. two new instruments, mass spectrometry services will be expanded to include high and low resolution electrospray ionization (ESl), tandem mass spectrometry (MSIMS), and LC-MS capabilities. Except for low resolution El and CI analyses, the Shared Resource is the only location at Purdue University where the above mass spectrometry techniques can be performed. This facility is overwhelmingly utilized for cancer-related research and derives considerable benefit from its participation in the Campus-Wide Mass Spectrometry Center (CWMSC), which insures service to the entire cancer research community at Purdue University. The Mass Spectrometry Shared Resource, in conjunction with the CWMSC, has several goals including: I) coordinating the operation and maintenance of mass spectrometers used for routine analyses, 2) providing research groups working on cancer related problems with access to all of the mass spectrometry technology on campus, 3) increasing awareness of the opportunities for problem solving by mass spectrometry, 4) coordinating the acquisition of new instrumentation as needs arise, and 5) developing new methods required to analyze user samples. Cancer Center members derive considerable benefit from the instrumentation and expertise provided by this Shared Resource and its personnel.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023168-21
Application #
6218814
Study Section
Project Start
1999-08-06
Project End
2000-06-30
Budget Start
Budget End
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Purdue University
Department
Type
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Onel, Buket; Carver, Megan; Agrawal, Prashansa et al. (2018) The 3'-end region of the human PDGFR-? core promoter nuclease hypersensitive element forms a mixture of two unique end-insertion G-quadruplexes. Biochim Biophys Acta Gen Subj 1862:846-854
Sorlien, Erin L; Witucki, Mary A; Ogas, Joseph (2018) Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio. J Vis Exp :
Mani, Saravana Kumar Kailasam; Andrisani, Ourania (2018) Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine :
Dong, Cheng; Dong, Guangping; Li, Li et al. (2018) An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2. Commun Biol 1:183
Morman, Rosemary E; Schweickert, Patrick G; Konieczny, Stephen F et al. (2018) BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice. Eur J Immunol 48:1492-1505
Zhang, Zhuangzhuang; Cheng, Lijun; Li, Jie et al. (2018) Inhibition of the Wnt/?-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Cancer Res 78:3147-3162
Rangasamy, Loganathan; Chelvam, Venkatesh; Kanduluru, Ananda Kumar et al. (2018) New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange. Bioconjug Chem 29:1047-1059
Zhang, Hao; Zhang, Yanqiu; Zhu, Xiaoyun et al. (2018) DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1. Hepatology :
Lee, Hyeon Jeong; Li, Jie; Vickman, Renee E et al. (2018) Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/?-catenin Pathway. Mol Cancer Res 16:974-985
Bhandari, Pushpak; Novikova, Gloriia; Goergen, Craig J et al. (2018) Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy. Sci Rep 8:3112

Showing the most recent 10 out of 436 publications